AIA Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 7:28 am

Competitors of AIA Engineering Ltd

All Competitor Stocks of AIA Engineering Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:10 pm

Below is a detailed analysis of the quarterly data for AIA Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,039.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,157.00 Cr. (Mar 2025) to 1,039.00 Cr., marking a decrease of 118.00 Cr..
• For Expenses, as of Jun 2025, the value is 733.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 855.00 Cr. (Mar 2025) to 733.00 Cr., marking a decrease of 122.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 306.00 Cr.. The value appears strong and on an upward trend. It has increased from 302.00 Cr. (Mar 2025) to 306.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 29.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2025) to 114.00 Cr., marking an increase of 16.00 Cr..
• For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 28.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 28.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 386.00 Cr.. The value appears strong and on an upward trend. It has increased from 363.00 Cr. (Mar 2025) to 386.00 Cr., marking an increase of 23.00 Cr..
• For Tax %, as of Jun 2025, the value is 21.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00%.
• For Net Profit, as of Jun 2025, the value is 305.00 Cr.. The value appears strong and on an upward trend. It has increased from 285.00 Cr. (Mar 2025) to 305.00 Cr., marking an increase of 20.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 32.34. The value appears strong and on an upward trend. It has increased from 30.24 (Mar 2025) to 32.34, marking an increase of 2.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:49 am

Growth

Last Updated: September 4, 2025, 10:25 pm

Balance Sheet

Last Updated: November 9, 2025, 1:35 pm

Below is a detailed analysis of the balance sheet data for AIA Engineering Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
• For Reserves, as of Sep 2025, the value is 7,348.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,908.00 Cr. (Mar 2025) to 7,348.00 Cr., marking an increase of 440.00 Cr..
• For Borrowings, as of Sep 2025, the value is 1,022.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 491.00 Cr. (Mar 2025) to 1,022.00 Cr., marking an increase of 531.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 500.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 416.00 Cr. (Mar 2025) to 500.00 Cr., marking an increase of 84.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 8,889.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,833.00 Cr. (Mar 2025) to 8,889.00 Cr., marking an increase of 1,056.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,140.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,175.00 Cr. (Mar 2025) to 1,140.00 Cr., marking a decrease of 35.00 Cr..
• For CWIP, as of Sep 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 23.00 Cr..
• For Investments, as of Sep 2025, the value is 4,791.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,919.00 Cr. (Mar 2025) to 4,791.00 Cr., marking an increase of 872.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,859.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,663.00 Cr. (Mar 2025) to 2,859.00 Cr., marking an increase of 196.00 Cr..
• For Total Assets, as of Sep 2025, the value is 8,889.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,833.00 Cr. (Mar 2025) to 8,889.00 Cr., marking an increase of 1,056.00 Cr..

Notably, the Reserves (7,348.00 Cr.) exceed the Borrowings (1,022.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for AIA Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 113.14. This value is within the healthy range. It has decreased from 120.40 (Mar 24) to 113.14, marking a decrease of 7.26.
• For Diluted EPS (Rs.), as of Mar 25, the value is 113.14. This value is within the healthy range. It has decreased from 120.40 (Mar 24) to 113.14, marking a decrease of 7.26.
• For Cash EPS (Rs.), as of Mar 25, the value is 123.38. This value is within the healthy range. It has decreased from 131.02 (Mar 24) to 123.38, marking a decrease of 7.64.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 742.28. It has increased from 706.95 (Mar 24) to 742.28, marking an increase of 35.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 742.28. It has increased from 706.95 (Mar 24) to 742.28, marking an increase of 35.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 459.43. It has decreased from 514.60 (Mar 24) to 459.43, marking a decrease of 55.17.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 158.68. This value is within the healthy range. It has decreased from 171.24 (Mar 24) to 158.68, marking a decrease of 12.56.
• For PBIT / Share (Rs.), as of Mar 25, the value is 147.64. This value is within the healthy range. It has decreased from 160.61 (Mar 24) to 147.64, marking a decrease of 12.97.
• For PBT / Share (Rs.), as of Mar 25, the value is 145.38. This value is within the healthy range. It has decreased from 157.60 (Mar 24) to 145.38, marking a decrease of 12.22.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 112.34. This value is within the healthy range. It has decreased from 120.39 (Mar 24) to 112.34, marking a decrease of 8.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 113.67. This value is within the healthy range. It has decreased from 120.40 (Mar 24) to 113.67, marking a decrease of 6.73.
• For PBDIT Margin (%), as of Mar 25, the value is 34.53. This value is within the healthy range. It has increased from 33.27 (Mar 24) to 34.53, marking an increase of 1.26.
• For PBIT Margin (%), as of Mar 25, the value is 32.13. This value exceeds the healthy maximum of 20. It has increased from 31.21 (Mar 24) to 32.13, marking an increase of 0.92.
• For PBT Margin (%), as of Mar 25, the value is 31.64. This value is within the healthy range. It has increased from 30.62 (Mar 24) to 31.64, marking an increase of 1.02.
• For Net Profit Margin (%), as of Mar 25, the value is 24.45. This value exceeds the healthy maximum of 10. It has increased from 23.39 (Mar 24) to 24.45, marking an increase of 1.06.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 24.74. This value exceeds the healthy maximum of 20. It has increased from 23.39 (Mar 24) to 24.74, marking an increase of 1.35.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.31. This value is within the healthy range. It has decreased from 17.05 (Mar 24) to 15.31, marking a decrease of 1.74.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.55. This value is within the healthy range. It has decreased from 22.45 (Mar 24) to 19.55, marking a decrease of 2.90.
• For Return On Assets (%), as of Mar 25, the value is 13.54. This value is within the healthy range. It has decreased from 15.15 (Mar 24) to 13.54, marking a decrease of 1.61.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 0.68 (Mar 24) to 0.55, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 8.17. This value exceeds the healthy maximum of 3. It has increased from 8.01 (Mar 24) to 8.17, marking an increase of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 6.88. This value exceeds the healthy maximum of 2. It has increased from 6.40 (Mar 24) to 6.88, marking an increase of 0.48.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.86. This value is below the healthy minimum of 4. It has increased from 1.62 (Mar 24) to 3.86, marking an increase of 2.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.22. This value is below the healthy minimum of 20. It has increased from 13.28 (Mar 24) to 14.22, marking an increase of 0.94.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.96. This value is below the healthy minimum of 20. It has increased from 12.21 (Mar 24) to 12.96, marking an increase of 0.75.
• For Earning Retention Ratio (%), as of Mar 25, the value is 85.78. This value exceeds the healthy maximum of 70. It has decreased from 86.72 (Mar 24) to 85.78, marking a decrease of 0.94.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.04. This value exceeds the healthy maximum of 70. It has decreased from 87.79 (Mar 24) to 87.04, marking a decrease of 0.75.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 70.21. This value is within the healthy range. It has increased from 56.91 (Mar 24) to 70.21, marking an increase of 13.30.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.70. This value is within the healthy range. It has increased from 41.01 (Mar 24) to 50.70, marking an increase of 9.69.
• For Enterprise Value (Cr.), as of Mar 25, the value is 31,295.18. It has decreased from 36,842.95 (Mar 24) to 31,295.18, marking a decrease of 5,547.77.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.30. This value exceeds the healthy maximum of 3. It has decreased from 7.59 (Mar 24) to 7.30, marking a decrease of 0.29.
• For EV / EBITDA (X), as of Mar 25, the value is 21.13. This value exceeds the healthy maximum of 15. It has decreased from 22.81 (Mar 24) to 21.13, marking a decrease of 1.68.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 7.61 (Mar 24) to 7.29, marking a decrease of 0.32.
• For Retention Ratios (%), as of Mar 25, the value is 85.77. This value exceeds the healthy maximum of 70. It has decreased from 86.71 (Mar 24) to 85.77, marking a decrease of 0.94.
• For Price / BV (X), as of Mar 25, the value is 4.51. This value exceeds the healthy maximum of 3. It has decreased from 5.55 (Mar 24) to 4.51, marking a decrease of 1.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 7.61 (Mar 24) to 7.29, marking a decrease of 0.32.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness